The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the Assessment of Multiple Addictions in a High-School Population: Prevalence and Related Disability By Stefano Pallanti, MD, PhD, Silvia Bernardi, MD, and Leonardo Quercioli, MD
Objective: Taking into account the importance of act prevention on the development of addictions, we assessed the presence of multiple addictions in an adolescent high-school population, also assessing the prevalence of Internet abuse and the impact on disability. Introduction: Adolescence seems to be a critical period of addiction vulnerability, based on social but also neurobiological factors. The earlier onset of behavioral/substance dependence seems to predict greater addiction severity, morbidity, and multiple addictive disorders. Methods: Data were collected from a sample of 275 students in Florence, Italy, high schools through surveys distributed in classes. The sample had an average age of 16.67±1.85 years (52.4% males, 47.6% females). To assess multiple addiction we used the 16 subscales of the Shorter PROMIS Questionnaire, to assess Internet addiction prevalence we used the Internet Addiction Scale, and to quantify disability symptoms, we used the Sheehan Disability Scale.
Needs Assessment Adolescence is a critical period of vulnerability to both substance and non-substance addictions. The investigation of the prevalence of multiple subthreshold addictions in this age group may be helpful in identifying predictive and risk factors. Learning Objectives At the end of this activity, the participant should be able to: • Define the most frequent appetitive behaviors in adolescents. • Identify which of these are the more frequent source of disability and in which field. • Consider the high disability of behavioral addictions apparently not as dangerous as Internet addictions. Target Audience: Neurologists and psychiatrists CME Accreditation Statement This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation The Mount Sinai School of Medicine designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Faculty Disclosure Policy Statement It is the policy of the Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material. This activity has been peer-reviewed and approved by Eric Hollander, MD, chair at the Mount Sinai School of Medicine. Review date: November 13, 2006. Dr. Hollander does not have an affiliation with or financial interest in any organization that might pose a conflict of interest. To Receive Credit for This Activity Read the three CME-designated articles, reflect on the information presented, and then complete the CME quiz. To obtain credits, you should score 70% or better. The estimated time to complete all three articles and the quiz is 3 hours.Release date: December 2006. Termination date: December 2008.
Dr. Pallanti is associate professor of psychiatry in the Department of Psychiatry and the director of the Institute...
Please join StudyMode to read the full document